Klp Kapitalforvaltning As »

Rapport Therapeutics shares owned by Klp Kapitalforvaltning As

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Klp Kapitalforvaltning As from 13F filings

Historical chart of Klp Kapitalforvaltning As investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Klp Kapitalforvaltning As consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Klp Kapitalforvaltning As

Quarter filed Position value Share count Share price at filing
2025-12-31 $179k 5.9k 30.34

More positions owned by Klp Kapitalforvaltning As

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)
Berkshire Hathaway Cl B New (BRK.B)
Johnson & Johnson (JNJ)
Mastercard Cl A (MA)

View all positions for Klp Kapitalforvaltning As

Top funds holding Rapport Therapeutics

TRV GP V
FMR
Arch Venture Corp
Capital Research and Management Company - Division 3
Cormorant Asset Management
Goldman Sachs Group
BlackRock
Sofinnova Ventures
Vanguard Group
Johnson & Johnson
Baker Bros. Advisors
Vestal Point Capital
Polar Capital Holdings
Trv Gp Vi
Ubs Global Asset Management Americas

View all funds holding Rapport Therapeutics